Melanie Wlassow
Overview
Explore the profile of Melanie Wlassow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ortonne V, Wlassow M, Hezode C, Francois M, Rosa I, Pawlotsky J, et al.
J Clin Virol
. 2021 Jun;
141:104873.
PMID: 34111663
No abstract available.
2.
Ortonne V, Wlassow M, Bouvier-Alias M, Melica G, Poveda J, Laperche S, et al.
Microorganisms
. 2021 Apr;
9(3).
PMID: 33799562
(1) Background: Sensitive and accurate nucleic acid amplification technologies are now recommended for hepatitis B virus (HBV) DNA detection and quantification in clinical practice to diagnose and monitor hepatitis B...
3.
Marcuccilli F, Chevaliez S, Muller T, Colagrossi L, Abbondanza G, Beyser K, et al.
Diagnostics (Basel)
. 2021 Mar;
11(2).
PMID: 33673365
Accurate measurement of the hepatitis B virus (HBV) DNA is important for the management of patients with chronic HBV infection. Here, the performance of the Xpert HBV Viral Load test...
4.
Chevaliez S, Wlassow M, Volant J, Roudot-Thoraval F, Bachelard A, Poiteau L, et al.
Open Forum Infect Dis
. 2020 Jul;
7(6):ofaa196.
PMID: 32617372
Background: Injecting drug use is a major driver of hepatitis C virus (HCV) spread worldwide, and the World Health Organization (WHO) has identified people who inject drugs (PWID) as a...
5.
Poiteau L, Wlassow M, Hezode C, Pawlotsky J, Chevaliez S
J Clin Virol
. 2020 Jun;
129:104481.
PMID: 32512377
Background: Accurate molecular methods to detect and quantify hepatitis B virus (HBV) DNA are essential to diagnose chronic infections, guide treatment decisions, assess response to treatment, and determine risk of...
6.
Wlassow M, Poiteau L, Roudot-Thoraval F, Rosa I, Soulier A, Hezode C, et al.
J Clin Virol
. 2019 Jun;
117:80-84.
PMID: 31254912
Background: Sensitive and accurate hepatitis C virus (HCV) RNA detection and quantification are essential to diagnose and monitor the virological response to antiviral treatment and the emergence of resistance. Objective...
7.
Rodriguez C, Mercier-Darty M, Soulier A, Poiteau L, Wlassow M, Fourati S, et al.
Antivir Ther
. 2019 May;
24(6):417-423.
PMID: 31112134
Background: International liver society guidelines recommended to perform HCV resistance testing at baseline of first-line therapy with certain combination regimens or prior to retreatment in patients previously exposed to a...
8.
Poiteau L, Soulier A, Lemoine M, Mohammed Z, Wlassow M, Rwegasha J, et al.
J Virol Methods
. 2018 Sep;
261:153-155.
PMID: 30176305
Rapid diagnostic tests (RDTs) represent an attractive alternative to conventional diagnostic methods for hepatitis C virus (HCV) infection. The aim of the present study was to assess the clinical performance...